Send to a Friend Share

SAC Capital Accumulates 5.8% Stake In Cubist Pharma (CBST)

April 17, 2011 9:13 PM EDT
CBST Hot Sheet
Overall Analyst Rating:
    BUY (Up Up)

EPS Growth %: -18.2%
In a 13G filing after the close Friday on Cubist Pharma. (Nasdaq: CBST), Steven Cohen's SAC Capital hedge fund disclosed a 5.8%, or 3,465,768 share, stake in the company.

The hedge fund held just 59,188 shares at the end of the latest quarter, 12/31/10.


Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In


Related Categories

13Gs, Hedge Funds

Related Entities

SAC Capital, Steven A. Cohen, Hedge Funds, 13G

Add Your Comment





Follow StreetInsider.com On Twitter